Stocktoria

Telomir Pharmaceuticals, Inc. TELO

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2024-02-09

Telomir Pharmaceuticals, Inc. statistics & valuation

Market cap$85.3M
P / B14.4×
Return on equity-176.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2022202320242025
Operating margin (%)
2022202320242025
Return on equity (%)
-380.20% -2571.00% -176.10% 2022202320242025
Shares outstanding
26.8M 28.6M 29.8M 34.4M 2022202320242025
Net debt ($)
2022202320242025
Share buybacks ($)
2022202320242025
Return on assets (%)
-1752.80% -273.80% -1248.70% -141.80% 2022202320242025
Free cash flow margin (%)
2022202320242025
Debt / equity (×)
2022202320242025
EPS ($)
-$0.03 $0.48 -$0.56 -$0.33 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Return on assets-141.8%-1248.7%-273.8%-1752.8%
Return on equity-176.1%-2571.0%-380.2%91.1%
Current ratio5.141.940.330.05

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.